24/7 Free Nationwide Case Review
A National Personal Injury Law Firm > Benicar Blood-Pressure Drug Subject of Lawsuits

Benicar Blood-Pressure Drug Subject of Lawsuits

Read about complications from taking Olmesartan from the lawyers who have helped plaintiffs with a Benicar lawsuit | Learn why many who took the medication are getting involved in Benicar class action lawsuits

The manufacturer of prescription blood-pressure drug Benicar, also known as Olmesartan, has been subject of growing lawsuits after patients claimed serious intestinal problems and complications.

Benicar is manufactured and sold by Forest Laboratories and Daiichi Sankyo to treat high blood pressure (hypertension) in adults and children. The drug is an angiotensin II receptor blocker (ARB) that keeps blood vessels from narrowing, thus lowering blood pressure and improve blood flow.

If you have taken Benicar and experienced intestinal side effects or other serious injuries contact us today about a Benicar lawsuit.

Benicar’s Danger to Pregnant Women

This medicine is not recommended for pregnant or breast-feeding women.

The Food and Drug Administration (FDA) classifies Benicar as a category D pregnancy drug, which means that it can cause injury or death to an unborn baby, especially during the second or third trimester.

benicar pregnant side effects

Greg Jones Law has sued many major drug manufacturers for failing to warn of the dangers of their drugs. To find out if you have a Benicar lawsuit case against the makers of Benicar (Olmesartan), contact us today for a free case evaluation.

Benicar Side Effects

If you take Benicar, you should be aware of its side effects and call a doctor if you experience dizziness, diarrhea, nausea, vomiting, headache, difficulty breathing or swallowing, and coughing.

Some patients taking this medicine reported severe weight loss and malnutrition from chronic diarrhea, nausea and vomiting. In many cases, after stopping Benicar the patients recovered.


The FDA approved the drug in 2002 and in 2013 was forced to change the label for all olmesartan single-ingredient and combination products to include intestinal problems (sprue-like enteropathy). This applied for all medicines marketed as Benicar, Benicar HCT, Azor, Tribenzor and its generic alternatives.

The label change came after a published article in the Mayo Clinic Proceedings said Benicar may be associated with a severe form of sprue-like enteropathy.

“Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. The enteropathy may develop months to years after starting olmesartan, and sometimes requires hospitalization. If patients taking olmesartan develop these symptoms and no other cause is found, the drug should be discontinued, and therapy with another antihypertensive started. Discontinuation of olmesartan has resulted in clinical improvement of sprue-like enteropathy symptoms in all patients”, said the FDA in its safety announcement.

“The earliest evidence of olmesartan-induced sprue-like enteropathy was identified in August 2012, and a few reports were published subsequently”, according to an article published in the U.S. National Library of Medicine, titled “Olmesartan and Drug-Induced Enteropathy”.

The Mayo Clinic Proceedings published the results of an evaluation of “unexplained chronic diarrhea and enteropathy while taking olmesartan”, which ruled out all cases with celiac disease and showed patients improved or recovered after discontinuation of the medicine.


Many patients have sued Daiichi Sankyo and Forest Laboratories for the harm they suffered after taking Benicar. Many reported suffering chronic diarrhea, severe weight loss, nausea, and vomiting. Some were required hospitalization to determine the cause of their ailment and underwent long-term medical care, expensive medical bills, loss of income and emotional distress.

The plaintiffs of these lawsuits seek to recover the cost of their treatments and regain financial stability. Claims have been made that Daiichi Sankyo and Forest Laboratories knew or should have known the risks of their product, and failed to warn the patients.

Pharmaceutical manufacturers should be held accountable for the injuries caused by their medicines if they are defective or dangerous. Sometimes, many lawsuits force manufacturers to fix their product or remove it from the market. In that way, taking legal action could play an important role in safeguarding public health and ensuring the reliability of prescription drugs.


Greg Jones Law is taking cases related to Benicar. If you or someone you know has suffered serious injuries from taking Benicar, consider your legal options.

Greg Jones Law has sued many major drug manufacturers for failing to warn of the dangers of their drugs. Our attorneys are ready to help you with a Benicar lawsuit. To find out if you have a case against the makers of Benicar (Olmesartan), contact us today for a free case evaluation. Call 855-Jones-Law or 855-566-3752 or contact us online.

We also have representatives waiting to chat with you online. You won’t be charged for the consultation. You’ll get a free no-hassle legal consultation for your peace of mind. We’re here to help!

Put an experienced Benicar lawyer on your side. Contact us today!

Learn More

benicar lawsuit

Benicar has been linked to serious intestinal problems.

Learn More about pharmaceutical litigation.

Discover the other dangerous drugs currently involved in litigation.

Contact us now

Free Consultation

Personal Injury

Practice Areas
  • Auto Accidents
  • Defective Medical Devices
  • Pharmaceutical Litigation
  • Social Security
  • + More